Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Mariela Agolti

Mariela Agolti

Centre of Nuclear Medicine, Argentina

Title: Review of our experience in 18 F-Choline PET CT in the diagnosis of bone metastasis for prostate carcinoma with biochemical relapse

Biography

Biography: Mariela Agolti

Abstract

Purpose : To review the bibliography and our results in the usefulness of 18 F-Choline PET fused with  CT  in prostate cancer to diagnose bone metastasis. Prostate cancer is the most common cancer in men in our country.

 

Methods: 18Fluorcholine ( 18FCH) PET CT  was  performed in 27   patients with prostate cancer using 0,035 Mci/kg in our  department of nuclear medicine  since 31/ 01/2017 to 01/08/2018  , we  included patients  with biopsy-proven prostate cancer with rise in PSA for restaging.

In our patient series, biochemical recurrence of prostate cancer was considered present when the levels of serum PSA measured after surgery or radiotherapy and/or hormonal therapy exceeded 0.1 ng /ml . Results were correlated with clinical, bio chemical and imaging follow up.

 

Results: We studied 27 patients. We found bone metastases in 10 patients, 15 patients were high risk patients, considering high risk when PSA was 10 or more and Gleason was 7 or more. We found hypermethabolic bone metastasis in 9 of this patients , only 2 of them had blastic images  in CT with normal 18 FCH uptake,  however in 2 of the 10 patients  with multiple bone metastasis , At least 50%of the lesions had no 18 FCH uptake . They were predominantly blastic.

 

Conclusion: 18 FCH PET CT is a very useful method for diagnosing bone metastasis in Prostate Cancer biochemical recurrence , however when they are very hyper dense in CT they may be not  uptake 18 FCH , in those cases the CT was used for bone metastasis diagnostic.